A Randomized, Open-label, Cross-over Phase 2 Trial of Darolutamide and Enzalutamide in Men with Asymptomatic or Mildly Symptomatic Metastatic Castrate-resistant Prostate Cancer: Patient Preference and Cognitive Function in ODENZA

Émeline Colomba, Sarah Flora Jonas, Jean‐Christophe Eymard, R. Delva, Pierre Emmanuel Brachet, Y. Neuzillet, Nicolas Penel, Guilhem Roubaud, Emmanuelle Bompas, Hakim Mahammedi, Raffaelle Longo, Carole Hélissey, Philippe Barthélémy, Delphine Borchiellini, Ali Hasbini, Franck Priou, Carolina Saldana, Éric Voog, Bérangère Narcisso, Sylvain Ladoire, Jean-François Berdah, Jean-Baptiste Aisenfarb, Stéphanie Foulon, Karim Fizazi